233 related articles for article (PubMed ID: 34920145)
21. T-lymphocyte-derived enkephalins reduce T
Basso L; Garnier L; Bessac A; Boué J; Blanpied C; Cenac N; Laffont S; Dietrich G
J Gastroenterol; 2018 Feb; 53(2):215-226. PubMed ID: 28424989
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-125a suppresses intestinal mucosal inflammation through targeting ETS-1 in patients with inflammatory bowel diseases.
Ge Y; Sun M; Wu W; Ma C; Zhang C; He C; Li J; Cong Y; Zhang D; Liu Z
J Autoimmun; 2019 Jul; 101():109-120. PubMed ID: 31014918
[TBL] [Abstract][Full Text] [Related]
23. Expression of TOB/BTG family members in patients with inflammatory bowel disease.
Fonseca-Camarillo G; Furuzawa-Carballeda J; Priego-Ranero ÁA; Martínez-Benítez B; Barreto-Zúñiga R; Yamamoto-Furusho JK
Scand J Immunol; 2021 Apr; 93(4):e13004. PubMed ID: 33247598
[TBL] [Abstract][Full Text] [Related]
24. miR-340 affects sauchinone inhibition of Th17 cell differentiation and promotes intestinal inflammation in inflammatory bowel disease.
Chen Q; He Q; Xiu W; Chen Y; Guo Z
Biochem Biophys Res Commun; 2020 Jun; 526(4):1157-1163. PubMed ID: 32321642
[TBL] [Abstract][Full Text] [Related]
25. IRF5 Acts as a Potential Therapeutic Marker in Inflammatory Bowel Diseases.
Yang Y; Zhang C; Jing D; He H; Li X; Wang Y; Qin Y; Xiao X; Xiong H; Zhou G
Inflamm Bowel Dis; 2021 Feb; 27(3):407-417. PubMed ID: 32737976
[TBL] [Abstract][Full Text] [Related]
26. miR-10a inhibits dendritic cell activation and Th1/Th17 cell immune responses in IBD.
Wu W; He C; Liu C; Cao AT; Xue X; Evans-Marin HL; Sun M; Fang L; Yao S; Pinchuk IV; Powell DW; Liu Z; Cong Y
Gut; 2015 Nov; 64(11):1755-64. PubMed ID: 25281418
[TBL] [Abstract][Full Text] [Related]
27. Elemental Diet Enriched with Amino Acids Alleviates Mucosal Inflammatory Response and Prevents Colonic Epithelial Barrier Dysfunction in Mice with DSS-Induced Chronic Colitis.
Guo D; Yang J; Ling F; Tu L; Li J; Chen Y; Zou K; Zhu L; Hou X
J Immunol Res; 2020; 2020():9430763. PubMed ID: 32855978
[TBL] [Abstract][Full Text] [Related]
28. CD4+CD25+ regulatory T cells suppress Th17-responses in an experimental colitis model.
Ogino H; Nakamura K; Ihara E; Akiho H; Takayanagi R
Dig Dis Sci; 2011 Feb; 56(2):376-86. PubMed ID: 20521112
[TBL] [Abstract][Full Text] [Related]
29. Endogenous regulation of visceral pain via production of opioids by colitogenic CD4(+) T cells in mice.
Boué J; Basso L; Cenac N; Blanpied C; Rolli-Derkinderen M; Neunlist M; Vergnolle N; Dietrich G
Gastroenterology; 2014 Jan; 146(1):166-75. PubMed ID: 24055279
[TBL] [Abstract][Full Text] [Related]
30. Sauchinone ameliorates intestinal inflammation and promotes Th17 cell production of IL-10 via Blimp-1.
Xiao J; Wang J; Chen Y; Zhou Z; Gao C; Guo Z
Biochem Biophys Res Commun; 2020 Feb; 522(2):435-441. PubMed ID: 31771884
[TBL] [Abstract][Full Text] [Related]
31. Il-21 enhances NK cell activation and cytolytic activity and induces Th17 cell differentiation in inflammatory bowel disease.
Liu Z; Yang L; Cui Y; Wang X; Guo C; Huang Z; Kan Q; Liu Z; Liu Y
Inflamm Bowel Dis; 2009 Aug; 15(8):1133-44. PubMed ID: 19322899
[TBL] [Abstract][Full Text] [Related]
32. Regulation of gut inflammation and th17 cell response by interleukin-21.
Fina D; Sarra M; Fantini MC; Rizzo A; Caruso R; Caprioli F; Stolfi C; Cardolini I; Dottori M; Boirivant M; Pallone F; Macdonald TT; Monteleone G
Gastroenterology; 2008 Apr; 134(4):1038-48. PubMed ID: 18395085
[TBL] [Abstract][Full Text] [Related]
33. Memory/effector (CD45RB(lo)) CD4 T cells are controlled directly by IL-10 and cause IL-22-dependent intestinal pathology.
Kamanaka M; Huber S; Zenewicz LA; Gagliani N; Rathinam C; O'Connor W; Wan YY; Nakae S; Iwakura Y; Hao L; Flavell RA
J Exp Med; 2011 May; 208(5):1027-40. PubMed ID: 21518800
[TBL] [Abstract][Full Text] [Related]
34. Expression of Programmed Death-Ligand 1 by Human Colonic CD90
Beswick EJ; Grim C; Singh A; Aguirre JE; Tafoya M; Qiu S; Rogler G; McKee R; Samedi V; Ma TY; Reyes VE; Powell DW; Pinchuk IV
Front Immunol; 2018; 9():1125. PubMed ID: 29910803
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1.
He C; Yu T; Shi Y; Ma C; Yang W; Fang L; Sun M; Wu W; Xiao F; Guo F; Chen M; Yang H; Qian J; Cong Y; Liu Z
Gastroenterology; 2017 May; 152(6):1434-1448.e15. PubMed ID: 28193514
[TBL] [Abstract][Full Text] [Related]
36. T-helper 17 and interleukin-17-producing lymphoid tissue inducer-like cells make different contributions to colitis in mice.
Ono Y; Kanai T; Sujino T; Nemoto Y; Kanai Y; Mikami Y; Hayashi A; Matsumoto A; Takaishi H; Ogata H; Matsuoka K; Hisamatsu T; Watanabe M; Hibi T
Gastroenterology; 2012 Nov; 143(5):1288-1297. PubMed ID: 22850180
[TBL] [Abstract][Full Text] [Related]
37. High salt diet stimulates gut Th17 response and exacerbates TNBS-induced colitis in mice.
Wei Y; Lu C; Chen J; Cui G; Wang L; Yu T; Yang Y; Wu W; Ding Y; Li L; Uede T; Chen Z; Diao H
Oncotarget; 2017 Jan; 8(1):70-82. PubMed ID: 27926535
[TBL] [Abstract][Full Text] [Related]
38. miR-155 deficiency protects mice from experimental colitis by reducing T helper type 1/type 17 responses.
Singh UP; Murphy AE; Enos RT; Shamran HA; Singh NP; Guan H; Hegde VL; Fan D; Price RL; Taub DD; Mishra MK; Nagarkatti M; Nagarkatti PS
Immunology; 2014 Nov; 143(3):478-89. PubMed ID: 24891206
[TBL] [Abstract][Full Text] [Related]
39. Innate PI3K p110δ regulates Th1/Th17 development and microbiota-dependent colitis.
Steinbach EC; Kobayashi T; Russo SM; Sheikh SZ; Gipson GR; Kennedy ST; Uno JK; Mishima Y; Borst LB; Liu B; Herfarth H; Ting JP; Sartor RB; Plevy SE
J Immunol; 2014 Apr; 192(8):3958-68. PubMed ID: 24634494
[TBL] [Abstract][Full Text] [Related]
40. Inhibiting PGGT1B Disrupts Function of RHOA, Resulting in T-cell Expression of Integrin α4β7 and Development of Colitis in Mice.
López-Posadas R; Fastancz P; Martínez-Sánchez LDC; Panteleev-Ivlev J; Thonn V; Kisseleva T; Becker LS; Schulz-Kuhnt A; Zundler S; Wirtz S; Atreya R; Carlé B; Friedrich O; Schürmann S; Waldner MJ; Neufert C; Brakebusch CH; Bergö MO; Neurath MF; Atreya I
Gastroenterology; 2019 Nov; 157(5):1293-1309. PubMed ID: 31302143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
